Annual Cash & Cash Equivalents
$83.95 M
-$89.74 M-51.67%
March 31, 2024
Summary
- As of February 7, 2025, ACB annual cash & cash equivalents is $83.95 million, with the most recent change of -$89.74 million (-51.67%) on March 31, 2024.
- During the last 3 years, ACB annual cash & cash equivalents has fallen by -$255.95 million (-75.30%).
- ACB annual cash & cash equivalents is now -75.30% below its all-time high of $339.91 million, reached on June 30, 2021.
Performance
ACB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$62.85 M
-$21.46 M-25.45%
September 1, 2024
Summary
- As of February 7, 2025, ACB quarterly cash and cash equivalents is $62.85 million, with the most recent change of -$21.46 million (-25.45%) on September 1, 2024.
- Over the past year, ACB quarterly cash and cash equivalents has dropped by -$45.97 million (-42.24%).
- ACB quarterly cash and cash equivalents is now -83.13% below its all-time high of $372.53 million, reached on March 31, 2021.
Performance
ACB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ACB Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -51.7% | -42.2% |
3 y3 years | -75.3% | - |
5 y5 years | -36.2% | - |
ACB Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -75.3% | at low | -81.8% | at low |
5 y | 5-year | -75.3% | at low | -83.1% | at low |
alltime | all time | -75.3% | >+9999.0% | -83.1% | >+9999.0% |
Aurora Cannabis Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $62.85 M(-25.5%) |
Jun 2024 | - | $84.32 M(+0.4%) |
Mar 2024 | $83.95 M(-51.7%) | $83.95 M(-22.9%) |
Dec 2023 | - | $108.83 M(+14.7%) |
Sep 2023 | - | $94.84 M(-20.4%) |
Jun 2023 | - | $119.12 M(-37.5%) |
Mar 2023 | $173.70 M(-48.9%) | - |
Dec 2022 | - | $190.62 M(-29.4%) |
Sep 2022 | - | $270.02 M(-20.5%) |
Jun 2022 | $339.77 M(-0.0%) | $339.77 M(-1.3%) |
Mar 2022 | - | $344.34 M(+32.1%) |
Dec 2021 | - | $260.70 M(-10.8%) |
Sep 2021 | - | $292.26 M(-14.0%) |
Jun 2021 | $339.91 M(+186.3%) | $339.91 M(-8.8%) |
Mar 2021 | - | $372.53 M(+23.6%) |
Dec 2020 | - | $301.44 M(+201.8%) |
Sep 2020 | - | $99.87 M(-15.9%) |
Jun 2020 | $118.74 M(-9.8%) | $118.74 M(-26.8%) |
Mar 2020 | - | $162.32 M(+35.6%) |
Dec 2019 | - | $119.68 M(+3.9%) |
Sep 2019 | - | $115.22 M(-12.4%) |
Jun 2019 | $131.57 M(+127.2%) | $131.57 M(-49.3%) |
Mar 2019 | - | $259.63 M(+656.1%) |
Dec 2018 | - | $34.34 M(-70.0%) |
Sep 2018 | - | $114.39 M(+97.5%) |
Jun 2018 | $57.92 M(-52.8%) | $57.92 M(-67.6%) |
Mar 2018 | - | $178.89 M(-35.9%) |
Dec 2017 | - | $279.00 M(+171.3%) |
Sep 2017 | - | $102.84 M(-16.3%) |
Jun 2017 | $122.80 M(>+9900.0%) | $122.80 M(+47.4%) |
Mar 2017 | - | $83.32 M(+101.2%) |
Dec 2016 | - | $41.42 M(+134.8%) |
Sep 2016 | - | $17.64 M(>+9900.0%) |
Jun 2016 | $131.40 K | $131.40 K(-50.2%) |
Mar 2016 | - | $264.00 K(-32.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | - | $391.80 K(-24.2%) |
Sep 2015 | - | $516.90 K(+103.1%) |
Jun 2015 | $254.50 K(-70.4%) | $254.50 K(+125.6%) |
Mar 2015 | - | $112.80 K(-79.9%) |
Dec 2014 | - | $561.00 K(-61.4%) |
Sep 2014 | - | $1.45 M(+69.2%) |
Jun 2014 | $859.30 K(+39.7%) | $859.30 K(+65.2%) |
Mar 2014 | - | $520.30 K(-1.3%) |
Dec 2013 | - | $527.20 K(-8.8%) |
Sep 2013 | - | $578.10 K(-6.0%) |
Jun 2013 | $615.20 K(-41.8%) | $615.20 K(-14.9%) |
Mar 2013 | - | $722.90 K(-16.8%) |
Dec 2012 | - | $868.50 K(-12.6%) |
Sep 2012 | - | $993.30 K(-6.0%) |
Jun 2012 | $1.06 M(-25.4%) | $1.06 M(-16.7%) |
Mar 2012 | - | $1.27 M(+6800.0%) |
Dec 2011 | - | $18.40 K(-33.1%) |
Sep 2011 | - | $27.50 K(-98.1%) |
Jun 2011 | $1.42 M(+1187.3%) | $1.42 M(+2384.2%) |
Mar 2011 | - | $57.00 K(+0.4%) |
Dec 2010 | - | $56.80 K(+64.6%) |
Sep 2010 | - | $34.50 K(-68.6%) |
Jun 2010 | $110.00 K(+1034.0%) | $110.00 K(+1095.7%) |
Mar 2010 | - | $9200.00(-99.4%) |
Dec 2009 | - | $1.65 M(+11.6%) |
Sep 2009 | - | $1.48 M(>+9900.0%) |
Jun 2009 | $9700.00(-99.4%) | $9700.00(-99.2%) |
Mar 2009 | - | $1.27 M(-3.7%) |
Dec 2008 | - | $1.31 M(-13.7%) |
Sep 2008 | - | $1.52 M(-4.7%) |
Jun 2008 | $1.60 M(+297.7%) | $1.60 M(-0.5%) |
Mar 2008 | - | $1.61 M(-4.4%) |
Dec 2007 | - | $1.68 M(+313.4%) |
Sep 2007 | - | $406.40 K |
Jun 2007 | $401.90 K | - |
FAQ
- What is Aurora Cannabis annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aurora Cannabis?
- What is Aurora Cannabis annual cash & cash equivalents year-on-year change?
- What is Aurora Cannabis quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aurora Cannabis?
- What is Aurora Cannabis quarterly cash and cash equivalents year-on-year change?
What is Aurora Cannabis annual cash & cash equivalents?
The current annual cash & cash equivalents of ACB is $83.95 M
What is the all time high annual cash & cash equivalents for Aurora Cannabis?
Aurora Cannabis all-time high annual cash & cash equivalents is $339.91 M
What is Aurora Cannabis annual cash & cash equivalents year-on-year change?
Over the past year, ACB annual cash & cash equivalents has changed by -$89.74 M (-51.67%)
What is Aurora Cannabis quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACB is $62.85 M
What is the all time high quarterly cash and cash equivalents for Aurora Cannabis?
Aurora Cannabis all-time high quarterly cash and cash equivalents is $372.53 M
What is Aurora Cannabis quarterly cash and cash equivalents year-on-year change?
Over the past year, ACB quarterly cash and cash equivalents has changed by -$45.97 M (-42.24%)